C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2009
11/25/2009	CN100562792C Two-order nonlinear laser material 4-nitro-N-oxy-2-pyridine carboxylic acid second-generation crystal, and its growth method and use
11/25/2009	CN100562516C Beta-amyloid protein production/secretion inhibitors
11/25/2009	CN100562320C Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1 lambda 6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide
11/24/2009	USRE41008 catalytic hydrogenation 5-arylnicotinic acids in presence of a palladium/ligand complex; intermediates for making N-alkylated amine; for crop protection, such as, fungicides, insecticides, herbicides or pesticides and drugs
11/24/2009	US7622595 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid
11/24/2009	US7622589 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists
11/24/2009	US7622475 3-{[(4-pyrazol-1-yl-benzyl)-(pyridine-3-sulfonyl)-amino]methyl}phenoxy)-acetic acid isopropyl ester; for reducing intraocular pressure in treating glaucoma, in a mammal
11/24/2009	US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis
11/24/2009	CA2561829C Crystal of 1,2-dihydropyridine compound and method for producing same
11/24/2009	CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2433197C Gyrase inhibitors and uses thereof
11/24/2009	CA2418794C Calcium receptor antagonists
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/24/2009	CA2337270C Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	US20090287025 Fluorinating agent and method for producing fluorine-containing compound using the same
11/19/2009	US20090286987 Metalloprotein inhibitors
11/19/2009	US20090286968 2-Quinoxalinol Salen Compounds and Uses Thereof
11/19/2009	US20090286841 Certain chemical entities, compositions, and methods
11/19/2009	US20090286818 Pyridine Non-Classical Cannabinoid Compounds and Related Methods of Use
11/19/2009	US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009	US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009	US20090286775 Bicyclic Derivatives as P38 Kinase Inhibitors
11/19/2009	US20090286275 Two-photon probe for real-time monitoring of intracellular free zinc ions, method for preparing the probe and method for real-time monitoring of intracellular free zinc ions using the probe
11/19/2009	US20090286261 Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin d synthase
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009	CA2724077A1 Amide compound
11/18/2009	EP2119706A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
11/18/2009	EP2117544A2 Biomarker identifying the reactivation of stat3 after src inhibition
11/18/2009	EP2018367B1 Novel microbiocides
11/18/2009	EP1893609B1 N-(pyridin-2-yl)-sulfonamide derivatives
11/18/2009	EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009	EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009	CN101583600A Acetylene derivatives as stearoyl CoA desaturase inhibitors
11/18/2009	CN101583599A N-hydroxyacrylamide compounds
11/18/2009	CN101583593A Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
11/18/2009	CN101580523A Novel chemical substance having activity for morphogenesis and growth promotion
11/18/2009	CN101580504A Organic compound, benzoxazole derivative, and light-emitting element using the benzoxazole derivative
11/18/2009	CN101580489A Nitrogenous heterocyclic ring compound and preparation method and application thereof
11/18/2009	CN101580488A Preparation method and application of tridentate pyridine imine ligand
11/18/2009	CN101580451A Novel organic electroluminescent compound and electroluminescent device using the same
11/17/2009	US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009	US7618969 Compounds which potentiate glutamate receptor and uses thereof in medicine
11/17/2009	CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009	CA2398992C Therapeutic or preventive agent for pulmonary insufficiency containing a diaminotrifluoromethylpyridine derivative
11/17/2009	CA2383364C Methods of preparing substituted tetracyclines with transition metal-based chemistries
11/12/2009	WO2009137596A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009	WO2009137412A1 Therapeutic compounds
11/12/2009	WO2009137411A1 Therapeutic compounds
11/12/2009	WO2009137404A1 Urea compounds as gamma secretase modulators
11/12/2009	WO2009137381A1 Synthesis of 4-[3-(2,6-dimethylbenzyloxy)phenyl]-4-oxobutanoic acid
11/12/2009	WO2009136617A1 Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal
11/12/2009	WO2009136365A1 Process for the preparation of 3,4-epoxy-2-amino-1-substituted butane derivatives and intermediate compounds thereof
11/12/2009	WO2009135860A1 Method for manufacturing aryl carboxamides
11/12/2009	WO2009135590A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
11/12/2009	WO2009117278A3 Processes for preparing (amino-pyrazolopyridinyl)methoxy substituted biaryl ethers
11/12/2009	WO2009100261A3 Improved process for making triphenylboron-pyridine compound
11/12/2009	US20090281325 Method for selectively producing primary amine compound
11/12/2009	US20090281319 Preparation of platinum (ii) complexes
11/12/2009	US20090281103 Renin Inhibitors
11/12/2009	US20090281089 Pyridyl inhibitors of hedgehog signalling
11/12/2009	US20090281066 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
11/12/2009	CA2723302A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
11/12/2009	CA2723237A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009	CA2723133A1 Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal
11/12/2009	CA2722606A1 Urea compounds as gamma secretase modulators
11/12/2009	CA2721695A1 Method for manufacturing aryl carboxamides
11/11/2009	EP2116535A1 Glucokinase-activating substance
11/11/2009	EP2116534A1 Process for production of binuclear metal complex
11/11/2009	EP2116533A1 Glucokinase activator
11/11/2009	EP2116532A1 Azapeptide derivatives as HIV protease inhibitors
11/11/2009	EP2116523A1 Rexinoid compound having alkoxy group
11/11/2009	EP2114893A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
11/11/2009	EP2114888A1 Tricyclic compounds and their use as glucocorticoid receptor modulators
11/11/2009	EP2114886A1 Process for the preparation of certain substituted sulfilimines
11/11/2009	EP2114884A1 Process for the preparation of 2-substituted-5-(1-alkylthio) alkylpyridines
11/11/2009	EP2114870A1 Synthetic ion channels
11/11/2009	EP2114867A1 Aminoamides as orexin antagonists
11/11/2009	EP2114405A1 Crystalline forms glyt1
11/11/2009	EP1742908B1 Non-nucleoside reverse transcriptase inhibitors
11/11/2009	EP1477186B1 Antipruritics
11/11/2009	EP1406870B1 Taxol enhancer compounds
11/11/2009	EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009	EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009	CN101578269A N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g.
11/11/2009	CN101578265A Sulfonamide derivatives as chymase inhibitors
11/11/2009	CN101578260A Insecticidal compounds
11/11/2009	CN101575735A Pyridine-2,4,6-triformate manganese ferro-electrical functional material and preparation method thereof
11/11/2009	CN100558722C A method for the preparation of enantiomerically pure mirtazapine
11/11/2009	CN100558705C N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
11/11/2009	CN100558701C N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009	CN100558428C Calcitonin gene related peptide receptor antagonists
11/11/2009	CN100558409C Thiotungstate analogues and uses thereof
11/11/2009	CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/10/2009	US7615641 esterification to form octacosanyl nicotinate; salt formation; use as anticholesterol agents treating cardiovascular disorders
11/10/2009	US7615568 3-[2-(cis-4-aminocyclohexyloxy)-4-methylsulfonylbenzoyl-amino]-N-(5-chloropyridin-2-yl)pyridine-2-carboxamide,; anticoagulant; platelet glycoprotein receptor antagonist; thrombosis; orally; acylation of amino-pyridine by (methylthio)benzoic acid followed by oxidation, alkylation, carbonylation
11/10/2009	US7615567 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome

1 ... 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 ... 633